Abstract
Renal sympathetic denervation is a novel and promising therapy option for patients with treatment-resistant primary arterial hypertension. By ablating renal sympathetic nerves in the wall of the renal artery, blood pressure decreases significantly without affecting renal function. This intervention is technically straightforward, and possible relevant procedure-specific complications are rare.
Extended indications are under investigation including milder forms of hypertension or heart failure. Future studies should reveal the full potential of this novel technique of blood pressure control possibly introducing renal sympathetic denervation into the clinical routine.
The kidney is an important player in blood pressure regulation. While the principles of blood pressure regulation by renin-angiotensin-aldosterone system, RAAS, have been to a large extent explored, the knowledge of blood pressure regulation via renal sympathetic innervation remains rudimentary. Nevertheless, it appears that continuously elevated renal sympathetic drive may be an important factor in the pathophysiology of arterial hypertension. In majority of these cases, antihypertensive drug regimes fail to lower blood pressure to target levels. Recently, reducing elevated (renal) sympathetic nerve activity by disrupting the interactions between the kidney and the sympathetic nervous system through catheter-based renal denervation has appeared as a potentially effective treatment option. The sympathetic renal nerves lie in the adventitia of the renal arteries approximately 3–4 mm abluminal, which makes them accessible for disruption by radiofrequency energy without any relevant collateral damage to the surrounding tissues. The endovascular concept of denervation of the renal sympathetic nerves includes the use of a radiofrequency catheter with a steerable electrode tip which is connected to a radiofrequency generator. Employing this novel endovascular technique, the early results in a limited number of patients showed a markedly improved blood pressure control in about 85% of treated patients [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Esler MD et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903–1909
Kearney PM et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217–223
Lewington S et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903–1913
Lubanski MS, McCullough PA (2009) Kidney’s role in hypertension. Minerva Cardioangiol 57(6):743–759
Mark AL (1996) The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl 14(5):S159–S165
DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75–197
Calhoun DA et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51(6):1403–1419
Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57(5):911–917
Mahfoud F et al (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123(18):1940–1946
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Id, D., Kaltenbach, B., Franke, J., Sievert, H. (2013). Renal Denervation. In: Lanzer, P. (eds) Catheter-Based Cardiovascular Interventions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27676-7_57
Download citation
DOI: https://doi.org/10.1007/978-3-642-27676-7_57
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27675-0
Online ISBN: 978-3-642-27676-7
eBook Packages: MedicineMedicine (R0)